This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Abivax, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 132 
1 out of 162 
Years Active: 2026
Title: Brice Sautier - Innovator in Pharmaceutical Compounds
Introduction: Brice Sautier is an inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for treating various diseases. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical treatments.
Latest Patent Applications: Brice Sautier has filed several patent applications, including:
1. **2-Methyl-Quinazolines**: This invention describes 2-methyl-quinazoline compounds of general formula (I). It includes methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that incorporate them. The 2-methyl substituted quinazoline compounds effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are particularly useful for treating hyperproliferative disorders, such as cancer, either as a sole agent or in combination with other active ingredients.
2. **Aryl-N-Aryl Derivatives for Treating RNA Virus Infection**: This application involves a compound of formula (I), which includes various functional groups and heterocycles. These compounds are designed to target RNA virus infections, showcasing the versatility and potential of Sautier's research in addressing viral diseases.
Conclusion: Brice Sautier is an innovative inventor whose work in pharmaceutical compounds holds promise for future medical advancements. His latest patent applications reflect a commitment to developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile